|
|
Other links at Articles > HIV/AIDS |
| 3. |
FDA Safety Changes: Aygestin, Viracept, Dipentum
|
|
|
The FDA has approved revisions to the safety labeling for norethindrone acetate tablets (Aygestin), nelfinavir mesylate tablets and oral powder (Viracept), and olsalazine sodium capsules (Dipentum). Medscape Medical News
|
|
|